Sarah Honig

Sarah Honig is a professional with a strong educational background and extensive experience in the fields of corporate development, business strategy, and biotechnology.

She holds a Master of Business Administration (MBA) from Harvard Business School, where she also completed her AB in History with a Secondary Degree in Chemistry. Sarah's academic journey began at Shalhevet high school, emphasizing her commitment to education.

Sarah has held notable positions in various prestigious organizations, showcasing her versatile skill set. Previously, she served as the Vice President of Corporate Development and Strategy at Tyra Biosciences, displaying her leadership abilities and strategic acumen.

Her professional endeavors also include roles such as Chief Of Staff at Allogene Therapeutics, Business Development at Amgen, and Investment Banking at Goldman Sachs. This diverse background highlights her adaptability and expertise in different sectors.

Sarah Honig has further enriched her experience through positions such as New Ventures at UCLA Technology Development Group, Consultant at Leerink Swann, and Researcher at respected institutions like the UCLA Human Gene Therapy Program and The Board of Governors Gene Therapeutic Research Institute at Cedars-Sinai Medical Center.

With her comprehensive academic foundation and extensive professional experience, Sarah Honig stands out as a dedicated and accomplished individual in the areas of corporate development, biotechnology, and business strategy.